| 000 | 01600 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512002612.0 | ||
| 264 | 0 | _c19890505 | |
| 008 | 198905s 0 0 eng d | ||
| 022 | _a0003-3022 | ||
| 024 | 7 |
_a10.1097/00000542-198904000-00022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, H M | |
| 245 | 0 | 0 |
_aSufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. _h[electronic resource] |
| 260 |
_bAnesthesiology _cApr 1989 |
||
| 300 |
_a672-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aEnkephalin, Methionine _xpharmacology |
| 650 | 0 | 4 |
_aFentanyl _xanalogs & derivatives |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMorphine _xpharmacology |
| 650 | 0 | 4 |
_aNeurons, Afferent _xdrug effects |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Opioid, kappa |
| 650 | 0 | 4 |
_aSpinal Cord _xphysiology |
| 650 | 0 | 4 |
_aSubstance P _xmetabolism |
| 650 | 0 | 4 | _aSufentanil |
| 700 | 1 | _aBerde, C B | |
| 700 | 1 | _aHolz, G G | |
| 700 | 1 | _aSteward, G F | |
| 700 | 1 | _aKream, R M | |
| 773 | 0 |
_tAnesthesiology _gvol. 70 _gno. 4 _gp. 672-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000542-198904000-00022 _zAvailable from publisher's website |
| 999 |
_c2473599 _d2473599 |
||